Ishares Genomics Immunology Etf Probability of Future Etf Price Finishing Over 24.08
| IDNA Etf | USD 24.08 0.53 2.15% |
IShares |
IShares Genomics Target Price Odds to finish over 24.08
The tendency of IShares Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 24.08 | 90 days | 24.08 | about 72.18 |
Based on a normal probability distribution, the odds of IShares Genomics to move above the current price in 90 days from now is about 72.18 (This iShares Genomics Immunology probability density function shows the probability of IShares Etf to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the etf has the beta coefficient of 1.01 . This usually indicates iShares Genomics Immunology market returns are sensitive to returns on the market. As the market goes up or down, IShares Genomics is expected to follow. Additionally IShares Genomics Immunology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. IShares Genomics Price Density |
| Price |
Predictive Modules for IShares Genomics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as iShares Genomics Imm. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.IShares Genomics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. IShares Genomics is not an exception. The market had few large corrections towards the IShares Genomics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold iShares Genomics Immunology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of IShares Genomics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.16 | |
β | Beta against Dow Jones | 1.01 | |
σ | Overall volatility | 0.51 | |
Ir | Information ratio | -0.13 |
IShares Genomics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of IShares Genomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for iShares Genomics Imm can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| iShares Genomics Imm generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Technical Pivots with Risk Controls - Stock Traders Daily | |
| iShares Genomics Imm created five year return of -2.0% | |
| This fund retains 99.56% of its assets under management (AUM) in equities |
IShares Genomics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of IShares Etf often depends not only on the future outlook of the current and potential IShares Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. IShares Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
IShares Genomics Technical Analysis
IShares Genomics' future price can be derived by breaking down and analyzing its technical indicators over time. IShares Etf technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of iShares Genomics Immunology. In general, you should focus on analyzing IShares Etf price patterns and their correlations with different microeconomic environments and drivers.
IShares Genomics Predictive Forecast Models
IShares Genomics' time-series forecasting models is one of many IShares Genomics' etf analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary IShares Genomics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the etf market movement and maximize returns from investment trading.
Things to note about iShares Genomics Imm
Checking the ongoing alerts about IShares Genomics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for iShares Genomics Imm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| iShares Genomics Imm generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Technical Pivots with Risk Controls - Stock Traders Daily | |
| iShares Genomics Imm created five year return of -2.0% | |
| This fund retains 99.56% of its assets under management (AUM) in equities |
Check out IShares Genomics Backtesting, Portfolio Optimization, IShares Genomics Correlation, IShares Genomics Hype Analysis, IShares Genomics Volatility, IShares Genomics History as well as IShares Genomics Performance. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
The market value of iShares Genomics Imm is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Genomics' value that differs from its market value or its book value, called intrinsic value, which is IShares Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Genomics' market value can be influenced by many factors that don't directly affect IShares Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.